4Filed May 19, 8:00 PM ET

SOPHiA GENETICS (SOPH) President Muken Ross Sells 761 Shares

$SOPH · SOPHiA GENETICS SA

Research Summary

AI-generated summary of this SEC filing

Updated

SOPHiA GENETICS (SOPH) President Muken Ross Sells 761 Shares

What Happened Muken Ross, President of SOPHiA GENETICS SA (SOPH), sold 761 shares on 2026-05-19 in open-market transactions. The weighted-average price reported was $4.60 per share (range $4.54–$4.66), for a total proceeds of $3,501. The filing indicates these sales were to satisfy tax withholding obligations related to RSUs and were executed under a pre-established Rule 10b5-1(c) plan (not discretionary).

Key Details

  • Transaction date: 2026-05-19 (Form 4 filed 2026-05-20). Filing appears timely.
  • Transaction type/code: Sale (S); open-market sale to cover tax withholding (F = tax withholding).
  • Shares sold: 761; weighted-average price: $4.60; price range: $4.54–$4.66.
  • Total proceeds: $3,501.
  • Footnotes: F1 — sale to satisfy tax withholding from RSU vesting on 2026-05-18; F2 — weighted average price with per-trade price range, and availability of per-price breakdown on written request.
  • Shares owned after transaction: Not specified in this filing.

Context These sales were executed pursuant to a pre-established 10b5-1 trading plan to cover withholding for vested restricted stock units, which is a routine administrative transaction and not an open-market discretionary sell signal. Retail investors should view this as tax-related selling rather than an explicit change in insider sentiment.